Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicure Inc.

www.medicure.com

Latest From Medicure Inc.

Zydus Ready For Moraiya Reinspection In June

Zydus says its Moraiya plant should be ready for re-inspection at the end of June 2020, following a recent FDA warning letter. Meanwhile, as returns from levorphanol fall on the back of increased competition, the firm has written down investment by $37.5m causing Q2 profits to slump 74%. Post successful Phase II trials in the US for NASH and NAFLD indications, its hopes are now pinned on saroglitazar magnesium.

Sales & Earnings Strategy

Levorphanol Write-Down Dents Zydus in Q2 But Saroglitazar Expectations Build

As returns from levorphanol fall on the back of increased competition, Zydus Cadila writes down investment by $37.5m causing Q2 profits to slump 74%. Post successful Phase II trials in the US for NASH and NAFLD indications, its hopes are now pinned on saroglitazar magnesium.

Commercial Sales & Earnings

Deal Watch: Ionis Turns To Affiliate Akcea In Amyloidosis

Biohaven restructures its migraine partnership with Bristol to reduce its downstream royalty commitments. Meanwhile, the pharma partners with GRYT Health's cancer app for patient/caregiver insights into cancer therapy.

Deals M & A

Zydus Partners Medicure To Launch First Branded Drug In US

Zydus Cadila is teaming up with Canada’s Medicure Inc to launch cholesterol control medication Zypitamag, its first branded drug in the key US market, as the Indian firm drives ahead with a strategy of diversifying from low-priced generics.

Commercial Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Lariat Capital Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Medicure Inc.
  • Senior Management
  • Albert D Friesen, PhD, Chmn. & CEO
    James Kinley, CFO
    Neil Owens, PhD, Pres. & COO
  • Contact Info
  • Medicure Inc.
    Phone: (204) 487-7412
    2-1250 Waverly St.
    Winnipeg, R3T 6C6
    Canada
UsernamePublicRestriction

Register